Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

At 9.6% CAGR, Global Cancer Gene Therapy Market Size Estimated to Cross USD 3.99 Billion Value By 2030: Polaris Market Research

Published

on

<!– Name:DistributionId Value:8756371 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1109402 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:d07b7034-86ae-4eca-aa0f-01888152829b –>

New York, NY, Feb. 24, 2023 (GLOBE NEWSWIRE) — Polaris Market Research has published a new research report titled “Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, Gene Transfer); By End-Use (Research Institutes, Biopharma Companies); By Region; Segment Forecast, 2022 – 2030” in its research database.

According to the research report, the global cancer gene therapy market size & share was valued at USD 1.76 Billion in 2021 and is expected to reach USD 3.99 Billion by 2030, growing at a CAGR of 9.6% during the forecast period.

What is Cancer Gene Therapy? How Big is Cancer Gene Therapy Market Size & Share?

As a new method of treating human diseases, gene therapy has rapidly gained traction. Cancer gene therapy is a new treatment that replaces a defective gene with a healthy gene inside the body’s cells to prevent or slow the growth of cancer, which is the second largest cause of death, according to the World Health Organization (WHO). With a wide variety of genes and vectors being utilized in clinical trials with positive results, this therapy method is incredibly adaptable.

Gene cancer techniques have been created to strengthen already available treatments like chemotherapy and immunotherapy. The increasing demand for gene therapy and the rising prevalence of cancer is anticipated to stimulate the cancer gene therapy market demand. Gene therapy is expected to develop into an effective alternative treatment for all cancers and neoplastic illnesses with the advent of technological advances in the field.

Request Sample Copy of Cancer Gene Therapy Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/cancer-gene-therapy-market/request-for-sample

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

Our Sample Report May Includes:

  • 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
  • 115+ Pages Research Report (Inclusion of Updated Research).
  • Provide Chapter-wise guidance on Requests.
  • 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
  • Includes Updated List of tables & figures.
  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.

Key Takeaways from This Report

  • The report presents an in-depth overview of the current structure and forecasts to help identify emerging business opportunities on which to capitalize.
  • The report elaborates on the SWOT analysis and Porter’s Five Forces model.
  • The market-study value chain review gives a good view of the positions of the stakeholders.
  • The report highlights key business strategies by major market players and their key methods.
  • The report evaluates region-specific growth and development in the market.

Some of the Top Market Players Are:

  • Altor Bioscience Corporation
  • SiBiono.
  • Shanghai Sunway Biotech Company Limited
  • BioCancell
  • GlobeImmune Inc.
  • Aduro Biotech
  • OncoGeneX
  • New Link Genetics.
  • ZioPharm Oncology
  • Genelux Corporation
  • Novartis AG
  • GlaxoSmithKline PLC (GSK)
  • Amgen Inc.
  • Bristol Myers
  • Squibb Company
  • Karyopharm Therapeutics Inc.
  • Gilead Sciences Inc.
  • Adaptimmune Limited
  • Sarepta Therapeutics Inc
  • Biogen
  • Orchard Therapeutics Plc
  • Spark Therapeutics Inc.
  • AGC Biologics
  • Anges

For Additional Information on Key Players, Download a PDF Brochure: https://www.polarismarketresearch.com/industry-analysis/cancer-gene-therapy-market/request-for-sample

Market Dynamics

Key Growth Driving Factors

  • Increasing investments in the R&D of gene therapies to drive the market growth

The rising focus on developing effective therapies and rising investments in cancer research are propelling the cancer gene therapy market size. Growing investment in research and development of gene therapies is driving the growth of the market. Rising number of cases of various types of cancers, such as breast, pancreatic, liver, brain, lung, colorectal, prostate, bladder, head and neck, skin, and ovarian, is encouraging specialists to develop effective therapies which are supporting the market growth. Further, factors like increased tobacco use, alcohol consumption, low physical activity, and low intake of fruits and vegetables, which have led to increased cancer development, are likely to fuel the industry expansion.

Recent Trends Influencing the Market

The introduction of new products in the market positively influences the industry expansion

  • Leading players are introducing new products with higher success rates and penetrating the significant untapped market. This is one of the key factors creating growth opportunities in the cancer gene therapy market. The industry is growing as a result of the availability of numerous cutting-edge medicines for ethically acceptable cancer treatment.
  • Furthermore, an increased number of significant research and development strategies carried out by biopharmaceutical firms to create new medicinal medications are contributing to the growth of the market. For instance, in August 2022, the FDA approved Bluebird Bio’s BLUE.O gene therapy for use in the treatment of patients with a rare condition that necessitates routine blood transfusions.

Request for a Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/cancer-gene-therapy-market/request-for-discount-pricing

Segmental Analysis

  • Gene-induced immunotherapy segment accounts for the largest market share in 2021

Based on therapy, the gene-induced immunotherapy category holds the major revenue share in the cancer gene therapy market due to a surge in investment in R&D and rising developments in gene technology. In gene-induced immunotherapy, DNA fragments called genes are generated in the body to immunize the body with beneficial genes. The genes are generated in order to kill the cancer cells and inhibit their growth in the body.

  • Hospitals are likely to capture the major cancer gene therapy market share

On the basis of end-use, the hospital category is predicted to dominate the market due to the growing prevalence of cancer.  With the increased demand for cancer gene therapy in hospitals, the market is estimated to see massive growth in the coming years. Another factor contributing to the expansion is the development of the healthcare infrastructure since hospitals now offer all treatments under one roof.

Cancer Gene Therapy Market: Report Scope

Report Attribute Details
Revenue forecast in 2030 USD 3.99 Billion
Market size value in 2021 USD 1.76 Billion
Expected CAGR Growth 9.6% from 2022 – 2030
Base Year 2021
Forecast Year 2022 – 2030
Top Market Players BioCancell, GlobeImmune, Inc., Aduro Biotech, OncoGeneX, New Link Genetics., ZioPharm Oncology, Genelux Corporation, Novartis AG, GlaxoSmithKline PLC (GSK), Amgen, Inc., Bristol Myers, Squibb Company, Karyopharm Therapeutics, Inc., Gilead Sciences, Inc., Adaptimmune Limited, Sarepta Therapeutics, Inc, Biogen, Orchard Therapeutics Plc
Segments Covered By Therapy, By End-Use, By Region
Customization Options Customized purchase options are available to meet any research needs. Explore customized purchase options

Geography Overview   

  • Asia Pacific is likely to grow at the fastest rate during the anticipated period

By geography, the cancer gene therapy market in North America witnessed the largest market share in 2021 and is expected to register a significant CAGR throughout the forecast period. This growth can be attributed to the increasing technological developments and growing investment in R&D. Also the presence of prominent industry players in the region is supporting the regional market growth.

Moreover, Asia Pacific is projected to capture higher CARG in the coming years owing to the rising geriatric population. Further, the expansion of the industry is aided by a surge in government spending and initiatives in the healthcare sector as well as technological improvements.

Browse the Detail Report “Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, Gene Transfer); By End-Use (Research Institutes, Biopharma Companies); By Region; Segment Forecast, 2022 – 2030” with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/cancer-gene-therapy-market           

For Additional Information OR Media Enquiry, Please Mail At: [email protected]

Recent Developments

  • In September 2022, At ESMO, GlaxoSmithKline (GSK) gave a presentation on the use of Zejula and Jemperli in treating specific cancers. GSK and iTeos also plan to begin research using the recently licensed cancer medicine dostarlimab.

The Report Answers Questions Such as

  • What is the market size and forecast of the industry?
  • What are the inhibiting factors and impact of key factors shaping the market during the forecast period?
  • Who are the key players operating in this market?
  • Which application/end-user or product type may seek incremental growth prospects?
  • What are the most significant challenges the market could face in the future?
  • What growth strategies are the players considering to stay in the market?

Polaris Market Research has segmented the cancer gene therapy market report based on therapy, end-use, and region:

By Therapy Outlook

  • Oncolytic Virotherapy
  • Gene-induced Immunotherapy
  • Gene transfer

By End-Use Outlook

  • Hospitals
  • Research Institutes
  • Biopharma Companies
  • Diagnostic centers
  • Others

By Region Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Browse More Related Reports:

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.

Contact:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: [email protected]
Web: https://www.polarismarketresearch.com

Follow Us: LinkedIn Twitter

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Picus Security Launches Security Validation for Kubernetes

Published

on

picus-security-launches-security-validation-for-kubernetes

Teams can eliminate container security exposures with the new enhancements in Picus’ platform for multi-cloud
SAN FRANCISCO, May 23, 2024 /PRNewswire/ — Picus Security, the Security Validation company, today announced security validation for Kubernetes. This new capability allows Security and DevOps teams to realize the benefits of containers securely by proactively measuring and optimizing the resilience of clusters. It is the latest innovative addition to the Picus Security Validation Platform, which empowers users to consistently validate their security posture and measure risk across on-premises and multi-cloud environments.

For organizations that want an agile way to deploy, run and scale applications, Kubernetes offers considerable benefits. However, security is often the biggest barrier to its adoption. The dynamic and complex nature of Kubernetes means that containers are often misconfigured due to human error. Without a hands-on approach to governance, security gaps can easily emerge over time, increasing the risk of incidents. This situation is exacerbated by the high level of expertise required to secure Kubernetes and the use of default settings which are inherently insecure. According to The State of Kubernetes Report, more than two-thirds of Kubernetes users (67%) have delayed deployments due to security concerns.* 
The addition of Kubernetes validation extends the Picus platform’s existing validation capabilities, which are powered by attack simulation and GenAI. It enables organizations to proactively identify and mitigate security misconfigurations, such as weak policies and settings that could allow containers to run with insecure privileges and facilitate lateral movement. Now security teams can automatically assess the security of their workloads wherever they are located – on-premises, in containers, and also in cloud platforms including Amazon Web Services, Google Cloud Platform, and Microsoft Azure.
“Cloud security is perhaps the biggest barrier of entry for organizations that want to take advantage of container orchestration,” said Volkan Erturk, Picus CTO and Co-Founder. “Kubernetes offers incredible opportunities for DevOps teams to deploy and scale new applications, but Security teams can struggle to keep pace.
“With the Picus Security Validation Platform, security concerns won’t slow down an organization’s digital transformation journey. This new offering will allow our users to consistently measure the security of their workloads and vastly reduce the effort needed to address exposures across growing IT environments.”
Additional Information
Read the Kubernetes validation announcement blog.Register for the upcoming webinar on July 11th 2024 at 10.00 EST/ 15.00 BST: Beyond Cloud Security Posture Management: Validating Cloud Effectiveness with Attack Simulation About Picus Security
Picus Security helps security teams consistently and accurately validate their security posture. Our Security Validation Platform simulates real-world threats to evaluate the effectiveness of security controls, identify high-risk attack paths to critical assets, and optimize threat prevention and detection capabilities.
As the pioneer of Breach and Attack Simulation, we specialize in delivering the actionable insights our customers need to be threat-centric and proactive. 
Picus is a Gartner® Peer Insights™ Customers’ Choice for 2024 in the BAS tools category†. The company is recognized as a leader by Frost & Sullivan^.
† Gartner, Voice of the Customer for Breach and Attack Simulation Tools, Peer Contributors, 30 January 2024 ^ Frost and Sullivan, 2022 Frost Radar™ report for the Global Breach and Attack Simulation Market
Logo: https://mma.prnewswire.com/media/2183222/4724563/Picus_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/picus-security-launches-security-validation-for-kubernetes-302154775.html

Continue Reading

Artificial Intelligence

Highlights from the Finale: Day Three of the London Blockchain Conference Unravelled

Published

on

highlights-from-the-finale:-day-three-of-the-london-blockchain-conference-unravelled

As the London Blockchain Conference draws to a close, attendees heard from industry experts on Driving Innovation with Blockchain.
LONDON, May 23, 2024 /PRNewswire/ — Attendees at the London Blockchain Conference were in to witness the final day, which featured a line-up of informative and thought-provoking speakers. Throughout the day, there were exciting panels and presentations which featured cutting-edge ideas and insights.

Day 3 kickstarted with BSVA launching a new report focusing on the role of blockchain in safeguarding data and streamlining transactions.
Other sessions included:
The Intersection of Web3, AI, and Emerging Tech – Somi Aran, Founder of InPeak gave the opening keynote which explored the dynamic convergence of Web3, Artificial Intelligence, and emerging technologies. She delved into how these technologies are reshaping industries and redefining the boundaries of innovation and the potential impacts and opportunities these technologies present.
Bridging the gap: Making Web3 technologies user-friendly – Christine Leong, CIO, nChain – discussed some of the innovative strategies and practical solutions aimed at simplifying Web3 technologies. She also discussed how nChain is planning to transform Web3 from a domain exclusive to the tech-savvy, into a user-friendly ecosystem that empowers all users.
Is code law? – Rules applicable to blockchain networks – panel featuring Marcin Zarakowski, CEO of Token Recovery, Akber Datoo CEO of D2 Legal Technology, Jeffrey Golden, King’s Counsel (Hon) at 3 Hare Court Chambers, Andrei Kirilenko, Professor of Finance at Cambridge Judge Business School, Professor Sarah Green, Law Commissioner at Law Commission, where they discussed that rules apply to the nodes and validators which support the particular network and process its transactions. The group also discussed whether the blockchain protocols’ rules and software code are the only sources of regulation in blockchain networks.
An Introduction to nChain Identity – Thomas Moretti, Head of Product Development at nChain. He spoke about the Self Sovereignty Identity concept and showcased the latest project it is working on – nChain Identity.
Reimagining Roles: How regulated industry leaders are shaping the future of finance – a panel featuring, Andrew Mosson (Chief Commercial Officer of OneTrading, Néstor Palao, Head DLT & Corporate Clients at Sygnum Bank, Laurence Lewandowska, CFO/COO at BSV Association and Wojciech Kaszycki Chairman & Founder at Mobilum. The panel discussed how the new era of digital assets, traditional banking institutions, exchanges, and financial services are being reimagined in the context of emerging technologies such as blockchain and AI.
Please register here if you would like to listen to any of the sessions today. 
If you want to interview any speaker from today’s sessions, please email [email protected].
About the London Blockchain Conference NETWORK. LEARN. ENGAGE.  At the London Blockchain Conference, we show how Blockchain will change the world and help people see another way to manage data, build scalable on-chain solutions and achieve great things. We do this by creating valuable, insightful, and engaging events that educate and inform, allowing you to connect and network to build strong business relationships. Our conference is the best avenue to see blockchain innovations, ecosystem announcements, product launches, technology updates, keynote speeches, panels, and fireside chats from blockchain leaders. Join us and experience it for yourself. 

View original content:https://www.prnewswire.co.uk/news-releases/highlights-from-the-finale-day-three-of-the-london-blockchain-conference-unravelled-302154546.html

Continue Reading

Artificial Intelligence

Nord Anglia Education publishes new insights on the role of AI and metacognition in learning

Published

on

nord-anglia-education-publishes-new-insights-on-the-role-of-ai-and-metacognition-in-learning

LONDON, May 23, 2024 /PRNewswire/ — INSIGHTS, the global publication from Nord Anglia Education, has published two new articles taking an in-depth look at AI in education and the role of metacognition in teaching and learning.

Exploring the role of AI in learning
https://www.nordangliaeducation.com/insights/2024/articles/the-generative-generationIn its ‘Generative Generation’ feature, INSIGHTS explores the role of artificial intelligence (AI) in education, and whether the technology is making it easier for children to learn. Speaking to Nord Anglia’s educators as well as leading experts from the world of academia, it also includes real-life examples of how Nord Anglia’s schools are using AI in the classroom.
For example, Nord Anglia’s British International School in Kuala Lumpur has adapted the technology to create an AI-powered teaching assistant that can personalise learning, guide students through content exploration, and deepen their understanding through interactive activities. Learners define the topic they want to explore and the course specification they are working to, and the AI explores the content with them in a conversational way, enabling them to ask questions as they go. 
Dr Bruce Geddes, Deputy Head of Secondary at the school, told INSIGHTS that AI represents “the biggest opportunity we’ve had in our lifetimes, for many, many spheres, but particularly in education”.
Avenues: The World School in New York, which became part of Nord Anglia in 2023, encourages its students to use AI in their work. As an example, in an app development project students use ChatGPT to generate the bulk of the coding, then review, correct and refine it. This saves them “hours of manual work by leveraging the appropriate tool in an academically appropriate way,” says Lia Muschellack, Director of Technology at the school.
The school also has its own generative AI chatbot, Savvy, built in 2019 and now powered by open AI technology. It can answer queries, provide information, and engage in “diverse discussions ranging from academic topics to casual conversations”.
“We understand that our students will be actively leveraging these tools throughout their academic and professional pathways, so we want to make sure they not only understand the potentials and limitations, but that they have tinkered and truly experienced them,” Muschellack explains.
Metacognition: a learning superpower
In its feature ‘Metacognition. Helping Kids Unlock the Power of ‘Thinking about Thinking’, INSIGHTS looks at how students can develop the important skill of metacognition.
“Metacognition is the ability to be aware of our cognitive or thought processes and to monitor, reflect on, and change those processes,” Dr Rose Luckin, Professor of Learner Centred Design at the University College London Knowledge Lab, told INSIGHTS.
Nord Anglia Education is working with Dr Luckin to develop its approach to metacognition and to help teachers introduce metacognitive strategies into classrooms. It has developed a metacognitive framework of six “Learner Ambitions” to help students develop the 6 Cs: to become critical, creative, committed, and curious learners, working compassionately and collaboratively in the classroom and beyond.
As the article explains, Nord Anglia’s deep dive into metacognition has many goals: developing student agency, boosting academic performance, and developing ‘future’ skills that employers want. The framework is being initially applied across 27 Nord Anglia schools around the world and its impact will be measured in independent research in partnership with Boston College, reporting in 2025.
Nord Anglia’s examination of metacognition also involves exploring personalised goals and thinking routines. For instance, students at Nord Anglia International School Hong Kong use the “Step In, Step Out, Step Back” routine to develop empathy and understanding in their studies. “It’s about asking the right questions; those really big questions that lead to even more questions,” says Raquel Thomson, the school’s Deputy Head of Primary. “Thinking strategies like this stay with students and serve a purpose whatever they do in their lives, whether they choose to be a scientist or a teacher or go into business.”
For media enquiries please contact: Francesca Milani Communications Manager, Digital Education Portfolio +44 20 7131 0000 [email protected] 
About Nord Anglia Education:
As the world’s leading international schools organisation, we’re shaping a generation of creative and resilient global citizens who graduate from our schools with everything they need for success, whatever they choose to be or do in life.  
Our strong academic foundations combine world-class teaching and curricula with cutting-edge technology and facilities, creating learning experiences like no other. Inside and outside of the classroom, we inspire our students to achieve more than they ever thought possible.  
No two children learn the same way, which is why our schools around the world personalise learning to what works best for every student. Inspired by our high-quality teachers, our students achieve outstanding academic results and go on to study at the world’s top universities.  
To learn more or apply for a place for your child, go to nordangliaeducation.com.
Logo: https://mma.prnewswire.com/media/1503193/3645357/Nord_Anglia_Education_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/nord-anglia-education-publishes-new-insights-on-the-role-of-ai-and-metacognition-in-learning-302154442.html

Continue Reading

Trending